<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117239">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01576783</url>
  </required_header>
  <id_info>
    <org_study_id>183210</org_study_id>
    <nct_id>NCT01576783</nct_id>
  </id_info>
  <brief_title>Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes</brief_title>
  <official_title>Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sarah Keim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allen Foundation Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>March of Dimes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cures Within Reach</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Resources and Services Administration (HRSA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine whether supplementation with certain polyunsaturated
      fatty acids can help the cognitive development of children born preterm.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Enrollment and Trial Completion</measure>
    <time_frame>Pre-baseline to 180 days post-randomization</time_frame>
    <description>The number of children who enroll in the trial and the proportion who return for study visits 2 and 3.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence</measure>
    <time_frame>Baseline to 180 days post-randomization</time_frame>
    <description>The proportion of children who adhere to the assigned supplement or placebo.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fatty Acid</measure>
    <time_frame>Baseline to 180 days post-randomization</time_frame>
    <description>Change in plasma and RBC fatty acid concentrations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Development</measure>
    <time_frame>Baseline to 180 days post-randomization</time_frame>
    <description>Changes in Bayley Scales of Infant and Toddler Development - 3rd edition scores from baseline to study visit 3.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Behavior</measure>
    <time_frame>Post-randomization</time_frame>
    <description>Differences in temperament (effortful control, activity level), social-emotional behavior, and sleep.</description>
  </other_outcome>
  <other_outcome>
    <measure>Body Composition</measure>
    <time_frame>Baseline to 180 days post-randomization</time_frame>
    <description>Changes in body composition from baseline to 6 months post-randomization (weight, recumbent length, head circumference, mid-upper arm circumference, triceps and subscapular skinfolds).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">448</enrollment>
  <condition>Preterm Birth</condition>
  <condition>Child Development</condition>
  <arm_group>
    <arm_group_label>DHA arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DHA+AA supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Corn oil supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DHA+AA</intervention_name>
    <description>200 mg DHA + 200 mg AA per day for 6 months</description>
    <arm_group_label>DHA arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>400 mg corn oil per day for 6 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 10-16 months (age corrected for prematurity) at baseline

          2. Discontinued regular breastfeeding and formula feeding at the time of randomization

          3. Gestational age &lt; 35 completed weeks at birth

          4. English is primary language in home

          5. Informed consent obtained and signed

          6. Child admitted to any NCH managed NICU or children who have ever had a Neonatology
             Clinic follow up visit scheduled, regardless of attendance

        Exclusion Criteria:

          1. Feeding problems

          2. Major malformation, metabolic, or digestive disorder that would preclude
             participation and/or optimal absorption of the supplement.

          3. Weight &lt; 5th or &gt; 95th percentile for age, per WHO growth charts

          4. Consume DHA supplement drops, chews, or powders or Pediasure, or fatty fish more than
             2x per week

          5. Plans to move out of the area within the next 6 months

          6. Known corn allergy

          7. Known soy allergy

          8. Known fish allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Months</minimum_age>
    <maximum_age>16 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Keim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 26, 2016</lastchanged_date>
  <firstreceived_date>April 10, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Sarah Keim</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
